You are here

A Phase 2 Study To Evaluate The Safety Of Apixaban In Atrial Fibrillation

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Nagoya, Aichi, Japan
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Atrial Fibrillation
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
20 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Age ≥ 20 years outpatient (regardless of sex)

- Patients diagnosed as non-valvular atrial fibrillation (NVAF)

- One or more following risks of stroke.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Recent cerebral infarction (includes TIA) within 4 weeks of week 0.

- Subjects who have or are suspected to have a serious/hereditary bleeding tendency,
such as disseminated intravascular coagulation syndrome (DIC), congenital platelet
dysfunction and von Willebrand disease (those suspected from the family history are
included).

- Subjects who have or are suspected to have a serious/hereditary thrombogenic tendency
(those suspected from the family history are included) or those who require
continuation of the Warfarin therapy.

NCT00787150
Pfizer
Completed
A Phase 2 Study To Evaluate The Safety Of Apixaban In Atrial Fibrillation

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Atrial Fibrillation
NCT03572972
All Genders
0+
Years
Seoul,

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now